HLA II类氨基酸多态性区分甲状腺与多腺体自身免疫
该免疫遗传学研究对587例多腺体自身免疫(AP)、自身免疫甲状腺病(AITD)、1型糖尿病(T1D)患者及健康对照进行HLA II类分型,分析肽结合槽氨基酸多态性。结果显示DQA1、DQB1和DRB1三个位点在AP与AITD及对照间均存在显著差异(P < .0001),7个氨基酸位点贡献于AP,5个DQA1位点完全相关(P < .0001)。HLA II类外显子2的氨基酸多态性介导AP风险并区分甲状腺与多腺体自身免疫。
要点
- HLA II类肽结合槽氨基酸多态性与多腺体自身免疫(AP)风险相关。
- AP与AITD及对照在DQA1、DQB1、DRB1位点分布差异显著(P < .0001)。
- DRB1-13、DRB1-26、DRB1-71、DRB1-74、DQA1-47、DQA1-56、DQB1-57与AP显著相关。
核心结论
- HLA II类外显子2的氨基酸多态性介导多腺体自身免疫风险,并可区分甲状腺自身免疫与多腺体自身免疫。
研究设计与样本
- 免疫遗传学研究,纳入587例多腺体自身免疫(AP)、自身免疫甲状腺病(AITD)、1型糖尿病(T1D)患者及健康无关对照,进行HLA II类分型。
主要发现
- Monte Carlo精确Fisher检验显示AP与AITD及对照在DQA1、DQB1和DRB1三个位点均存在显著差异(P < .0001)。
- AP II型(以Addison病为主要内分泌成分)与AP III型(T1D + AITD)之间也存在显著差异。
- AP与T1D在DRB1等位基因上差异显著(P < .041)。
- 七个氨基酸位点DRB1-13、DRB1-26、DRB1-71、DRB1-74、DQA1-47、DQA1-56和DQB1-57显著贡献于AP。
- DQA1的五个位点(11、47、50、56和69)完全相关(P < .0001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The structure of the human leucocyte antigen (HLA) peptide-binding clefts strongly contributes to monoglandular and polyglandular autoimmunity (AP). OBJECTIVE: To investigate the impact of amino acid polymorphisms on the peptide-binding interactions within HLA class II and its association with AP. DESIGN: Immunogenetic study. SETTING: Tertiary referral center for autoimmune endocrine diseases. SUBJECTS: 587 subjects with AP, autoimmune thyroid disease (AITD), type 1 diabetes (T1D), and healthy unrelated controls were typed for HLA class II. METHODS: Amino acids within the peptide binding cleft that are encoded by HLA class II exon 2 were listed for all codon positions in all subjects. Overall comparisons between disease and control groups with respect to allele distribution at a given locus were performed by assembling rare alleles applying an exact Freeman Halton contingency table test with Monte-Carlo P values based on 150 000 samples. RESULTS: The Monte Carlo exact Fisher test demonstrated marked differences in all 3 loci, DQA1, DQB1, and DRB1 (P < .0001) between AP and both AITD and controls, as well as between AP type II (Addison's disease as a major endocrine component) and AP type III (T1D + AITD). Differences were also noted between AP and T1D pertaining to the DRB1 allele (P < .041). Seven amino acid positions, DRB1-13, DRB1-26, DRB1-71, DRB1-74, DQA1-47, DQA1-56, and DQB1-57, significantly contributed to AP. Five positions in DQA1 (11, 47, 50, 56, and 69) completely correlated (P < .0001). CONCLUSION: Amino acid polymorphisms within HLA class II exon 2 mediate the AP risk and differentiate between thyroid and polyglandular autoimmunity.
引用
- Frommer L, Flesch BK, König J, et al. Amino Acid Polymorphisms in Hla Class II Differentiate Between Thyroid and Polyglandular Autoimmunity. J Clin Endocrinol Metab. 2020. PMID: 31675055. doi:10.1210/clinem/dgz164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。